Skip to content

The anatomical partial lobectomy based on watershed analysis in the treatment of early-stage peripheral lung cancer: a single center, prospective, randomized, controlled trail

The anatomical partial lobectomy based on watershed analysis in the treatment of early-stage peripheral lung cancer: a single center, prospective, randomized, controlled trail

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059083
Enrollment
Unknown
Registered
2022-04-24
Start date
2022-05-09
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early-stage Peripheral Pulmonary Carcinoma

Interventions

Segmental pneumonectomy group:Conventional anatomic partial lobectomy,Fluorescence back staining to determine the plane between segments
Segmental pneumonectomy based on watershed analysis group:pulmonary artery was severed and the vein and bronchus were preserved,Fluorescence back staining to determine the plane between segments

Sponsors

Fuzhou Pulmonary Hospital of Fujian
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Nodules = 50%; 3. Nodule doubling time >= 400 days.

Exclusion criteria

Exclusion criteria: 1. Elderly patients with various medical diseases, poor cardiopulmonary function and intolerance to segmental pneumonectomy; 2. History of pneumoconiosis and tuberculosis estimates severe bronchial and perivascular adhesions; 3. Preoperative examination and examination have complications and previous history that affect the operation index, or other complications that affect the operation.

Design outcomes

Primary

MeasureTime frame
Age;Sex;Tissue type;Tumor size;TNM stage;Lymph node metastasis;Extended resection or not;Operation time;Bleeding volume;Postoperative hemoptysis or not;Length of stay;

Countries

China

Contacts

Public ContactZhang Nan

Fuzhou Pulmonary Hospital of Fujian

zhangnan235@126.com+86 18950424918

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026